CM
CM Management Portfolio holdings
AUM
$157M
Turnover
30.95%
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.23%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$10.3M
(+10%)
Cap. Flow
+$6.19M
Cap. Flow
% of AUM
5.63%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
76
New
22
Increased
18
Reduced
15
Closed
9
Avg Time Held
2
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$1.81M |
| 2 |
MarineMax
HZO
|
+$1.77M |
| 3 |
Winnebago Industries
WGO
|
+$1.31M |
| 4 |
Pfizer
PFE
|
+$1.05M |
| 5 |
Cognyte Software
CGNT
|
+$984K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$2.65M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$2.48M |
| 3 |
Cytokinetics
CYTK
|
+$1.61M |
| 4 |
ARKO Corp
ARKO
|
+$1.53M |
| 5 |
Cohu
COHU
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.09% |
| 2 | Technology | 10.92% |
| 3 | Materials | 10.24% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
DELISTED
Xoma
XOMA
| $1.61M | 1.47% |
64,000
| – | – |
2023 Q4
6 quarters
|
|
27
Evolus
EOLS
$477M
| $1.61M | 1.47% |
175,000
+25,000
| +17% | +$256K |
2023 Q2
8 quarters
|
|
28
Cytosorbents Corp
CTSO
$9.74M
| $1.6M | 1.46% |
62,500
+14,796
| +31% | +$297K |
2021 Q1
17 quarters
|
|
29
PagerDuty
PD
$1.31B
| $1.53M | 1.39% |
100,000
-50,000
| -33% | -$777K |
2023 Q2
8 quarters
|
|
30
First Financial Corp
THFF
$868M
| $1.52M | 1.38% |
28,000
-14,500
| -34% | -$722K |
2024 Q1
5 quarters
|
|
31
Heron Therapeutics
HRTX
$68.7M
| $1.24M | 1.13% |
600,000
| – | – |
2020 Q4
18 quarters
|
|
32
Iovance Biotherapeutics
IOVA
$6.44B
| $1.2M | 1.1% |
700,000
+200,000
| +40% | +$498K |
2023 Q3
7 quarters
|
|
33
Nektar Therapeutics
NKTR
$1.26B
| $1.16M | 1.06% |
45,000
-8,333
| -16% | -$93.6K |
2020 Q4
18 quarters
|
|
|
34
Winnebago Industries
WGO
$653M
| $1.16M | 1.06% |
+40,000
| New | +$1.31M |
2025 Q2
0 quarters
|
|
35
Coya Therapeutics
COYA
$98.1M
| $1.15M | 1.05% |
200,000
| – | – |
2023 Q2
8 quarters
|
|
|
36
Pfizer
PFE
$166B
| $1.09M | 0.99% |
+45,000
| New | +$1.05M |
2025 Q2
0 quarters
|
|
37
Eledon Pharmaceuticals
ELDN
$183M
| $1.02M | 0.93% |
375,000
+100,000
| +36% | +$300K |
2021 Q1
17 quarters
|
|
38
Bristow Group
VTOL
$1.17B
| $989K | 0.9% |
+30,000
| New | +$905K |
2025 Q2
0 quarters
|
|
39
AMCON Distributing
DIT
$61.3M
| $986K | 0.9% |
13,428
+297
| +2% | +$22.2K |
2020 Q4
18 quarters
|
|
40
RenaissanceRe
RNR
$14.1B
| $972K | 0.88% |
+4,000
| New | +$969K |
2025 Q2
0 quarters
|
|
|
SVC
41
Service Properties Trust
SVC
$758M
| $956K | 0.87% |
80,000
-10,000
| -11% | -$108K |
2021 Q3
15 quarters
|
|
|
42
Cognyte Software
CGNT
$619M
| $924K | 0.84% |
+100,000
| New | +$984K |
2025 Q2
0 quarters
|
|
43
APA Corp
APA
$16.6B
| $915K | 0.83% |
+50,000
| New | +$867K |
2025 Q2
0 quarters
|
|
44
Copa Holdings
CPA
$5.35B
| $880K | 0.8% |
+8,000
| New | +$790K |
2025 Q2
0 quarters
|
|
45
Innospec
IOSP
$2.39B
| $841K | 0.77% |
+10,000
| New | +$875K |
2025 Q2
0 quarters
|
|
46
First Solar
FSLR
$19.2B
| $828K | 0.75% |
+5,000
| New | +$738K |
2025 Q2
0 quarters
|
|
47
Adobe
ADBE
$93.7B
| $774K | 0.7% |
+2,000
| New | +$771K |
2025 Q2
0 quarters
|
|
48
OS Therapies Inc
OSTX
$65.1M
| $705K | 0.64% |
375,000
+75,000
| +25% | +$126K |
2024 Q3
3 quarters
|
|
49
Everest Group
EG
$14.4B
| $680K | 0.62% |
+2,000
| New | +$690K |
2025 Q2
0 quarters
|
|
50
SLB Ltd
SLB
$72B
| $676K | 0.62% |
+20,000
| New | +$694K |
2025 Q2
0 quarters
|
|
Similar funds
SFSG
PTFIS
AWMG
LDNAM
DFS
APW
GA
TC
CM Management's Q2 2025 Portfolio in Review
As of Q2 2025, CM Management held 76 positions worth $110M, up 10% from $99.5M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
CM Management deployed $6.19M of net new capital in Q2 2025, opening 22 new positions and adding to 18 existing holdings. Its largest new stake was IQVIA: 12,000 shares worth $1.89M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was ARKO Corp, an estimated $1.53M trimmed.
- CM Management's largest Q2 2025 buy was IQVIA: 12,000 shares worth $1.89M.
- CM Management added most to Warner Bros in Q2 2025, an estimated $933K increase.
- CM Management's biggest Q2 2025 reduction was ARKO Corp, cutting an estimated $1.53M.
- CM Management fully exited Freeport-McMoran in Q2 2025, selling an estimated $2.65M.
- CM Management's ten largest holdings make up 40% of its $110M portfolio in Q2 2025.
- CM Management opened 22 new positions and closed 9 in Q2 2025.
- CM Management's portfolio value rose 10% quarter-over-quarter to $110M.
Based on CM Management's 13F filing for Q2 2025, filed 12 Aug 2025.